The original version of this article unfortunately contained a mistake. Section “Results”, second paragraph, first sentence should read: The plasma levels of NT-proBNP were significantly higher in patients who had AF at baseline, with a median of 3417 pg/mL (1897–6486), as compared with patients who were in SR at baseline; both those who had a history of AF (1788 pg/mL [682–3870], p < 0.001) and those who never had AF before (2231 pg/mL [902–5270], p < 0.001) (Table 1), also after multivariable adjustment (Table 2).
Correction to: The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure (Clinical Research in Cardiology, (2020), 109, 3, (331-338), 10.1007/s00392-019-01513-y) / Santema, B.T., Chan, M.M.Y., Tromp, J., Dokter, M., Van Der Wal, H.H., Emmens, J.E., Takens, J., Samani, N.J., Ng, L.L., Lang, C.C., Van Der Meer, P., Ter Maaten, J.M., Damman, K., Dickstein, K., Cleland, J.G., Zannad, F., Anker, S.D., Metra, M., Van Der Harst, P., De Boer, R.A., et al.. - In: CLINICAL RESEARCH IN CARDIOLOGY. - ISSN 1861-0684. - (2021). [10.1007/s00392-020-01762-2]
Correction to: The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure (Clinical Research in Cardiology, (2020), 109, 3, (331-338), 10.1007/s00392-019-01513-y)
Metra M.;
2021-01-01
Abstract
The original version of this article unfortunately contained a mistake. Section “Results”, second paragraph, first sentence should read: The plasma levels of NT-proBNP were significantly higher in patients who had AF at baseline, with a median of 3417 pg/mL (1897–6486), as compared with patients who were in SR at baseline; both those who had a history of AF (1788 pg/mL [682–3870], p < 0.001) and those who never had AF before (2231 pg/mL [902–5270], p < 0.001) (Table 1), also after multivariable adjustment (Table 2).I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
